Global Anti-PD-1 MAb Sales Market Report 2024

Report ID: 884746 | Published Date: Jan 2025 | No. of Page: 137 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Anti-PD-1 MAb Market Overview
    1.1 Anti-PD-1 MAb Product Scope
    1.2 Anti-PD-1 MAb Segment by Type
        1.2.1 Global Anti-PD-1 MAb Sales by Type (2016 & 2021 & 2027)
        1.2.2 40mg
        1.2.3 100mg
        1.2.4 200mg
        1.2.5 Others
    1.3 Anti-PD-1 MAb Segment by Application
        1.3.1 Global Anti-PD-1 MAb Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 Melanoma Patients
        1.3.3 Lung Cancer Patients
        1.3.4 Lymphoma Patients
        1.3.5 Other
    1.4 Anti-PD-1 MAb Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Anti-PD-1 MAb Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Anti-PD-1 MAb Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Anti-PD-1 MAb Price Trends (2016-2027)

2 Anti-PD-1 MAb Estimates and Forecasts by Region
    2.1 Global Anti-PD-1 MAb Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Anti-PD-1 MAb Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Anti-PD-1 MAb Sales Market Share by Region (2016-2021)
        2.2.2 Global Anti-PD-1 MAb Revenue Market Share by Region (2016-2021)
    2.3 Global Anti-PD-1 MAb Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Anti-PD-1 MAb Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Anti-PD-1 MAb Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Anti-PD-1 MAb Estimates and Projections (2016-2027)
        2.4.2 Europe Anti-PD-1 MAb Estimates and Projections (2016-2027)
        2.4.3 China Anti-PD-1 MAb Estimates and Projections (2016-2027)
        2.4.4 Japan Anti-PD-1 MAb Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Anti-PD-1 MAb Estimates and Projections (2016-2027)
        2.4.6 India Anti-PD-1 MAb Estimates and Projections (2016-2027)
3 Global Anti-PD-1 MAb Competition Landscape by Players
    3.1 Global Top Anti-PD-1 MAb Players by Sales (2016-2021)
    3.2 Global Top Anti-PD-1 MAb Players by Revenue (2016-2021)
    3.3 Global Anti-PD-1 MAb Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-PD-1 MAb as of 2020)
    3.4 Global Anti-PD-1 MAb Average Price by Company (2016-2021)
    3.5 Manufacturers Anti-PD-1 MAb Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Anti-PD-1 MAb Market Size by Type
    4.1 Global Anti-PD-1 MAb Historic Market Review by Type (2016-2021)
        4.1.1 Global Anti-PD-1 MAb Sales Market Share by Type (2016-2021)
        4.1.2 Global Anti-PD-1 MAb Revenue Market Share by Type (2016-2021)
        4.1.3 Global Anti-PD-1 MAb Price by Type (2016-2021)
    4.2 Global Anti-PD-1 MAb Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Anti-PD-1 MAb Sales Forecast by Type (2022-2027)
        4.2.2 Global Anti-PD-1 MAb Revenue Forecast by Type (2022-2027)
        4.2.3 Global Anti-PD-1 MAb Price Forecast by Type (2022-2027)
5 Global Anti-PD-1 MAb Market Size by Application
    5.1 Global Anti-PD-1 MAb Historic Market Review by Application (2016-2021)
        5.1.1 Global Anti-PD-1 MAb Sales Market Share by Application (2016-2021)
        5.1.2 Global Anti-PD-1 MAb Revenue Market Share by Application (2016-2021)
        5.1.3 Global Anti-PD-1 MAb Price by Application (2016-2021)
    5.2 Global Anti-PD-1 MAb Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Anti-PD-1 MAb Sales Forecast by Application (2022-2027)
        5.2.2 Global Anti-PD-1 MAb Revenue Forecast by Application (2022-2027)
        5.2.3 Global Anti-PD-1 MAb Price Forecast by Application (2022-2027)

6 North America Anti-PD-1 MAb Market Facts & Figures
    6.1 North America Anti-PD-1 MAb Sales by Company
        6.1.1 North America Anti-PD-1 MAb Sales by Company (2016-2021)
        6.1.2 North America Anti-PD-1 MAb Revenue by Company (2016-2021)
    6.2 North America Anti-PD-1 MAb Sales Breakdown by Type
        6.2.1 North America Anti-PD-1 MAb Sales Breakdown by Type (2016-2021)
        6.2.2 North America Anti-PD-1 MAb Sales Breakdown by Type (2022-2027)
    6.3 North America Anti-PD-1 MAb Sales Breakdown by Application
        6.3.1 North America Anti-PD-1 MAb Sales Breakdown by Application (2016-2021)
        6.3.2 North America Anti-PD-1 MAb Sales Breakdown by Application (2022-2027)

7 Europe Anti-PD-1 MAb Market Facts & Figures
    7.1 Europe Anti-PD-1 MAb Sales by Company
        7.1.1 Europe Anti-PD-1 MAb Sales by Company (2016-2021)
        7.1.2 Europe Anti-PD-1 MAb Revenue by Company (2016-2021)
    7.2 Europe Anti-PD-1 MAb Sales Breakdown by Type
        7.2.1 Europe Anti-PD-1 MAb Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Anti-PD-1 MAb Sales Breakdown by Type (2022-2027)
    7.3 Europe Anti-PD-1 MAb Sales Breakdown by Application
        7.3.1 Europe 137 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 137 Sales Breakdown by Application (2022-2027)

8 China Anti-PD-1 MAb Market Facts & Figures
    8.1 China Anti-PD-1 MAb Sales by Company
        8.1.1 China Anti-PD-1 MAb Sales by Company (2016-2021)
        8.1.2 China Anti-PD-1 MAb Revenue by Company (2016-2021)
    8.2 China Anti-PD-1 MAb Sales Breakdown by Type
        8.2.1 China Anti-PD-1 MAb Sales Breakdown by Type (2016-2021)
        8.2.2 China Anti-PD-1 MAb Sales Breakdown by Type (2022-2027)
    8.3 China Anti-PD-1 MAb Sales Breakdown by Application
        8.3.1 China 241 Sales Breakdown by Application (2016-2021)
        8.3.2 China 241 Sales Breakdown by Application (2022-2027)

9 Japan Anti-PD-1 MAb Market Facts & Figures
    9.1 Japan Anti-PD-1 MAb Sales by Company
        9.1.1 Japan Anti-PD-1 MAb Sales by Company (2016-2021)
        9.1.2 Japan Anti-PD-1 MAb Revenue by Company (2016-2021)
    9.2 Japan Anti-PD-1 MAb Sales Breakdown by Type
        9.2.1 Japan Anti-PD-1 MAb Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Anti-PD-1 MAb Sales Breakdown by Type (2022-2027)
    9.3 Japan Anti-PD-1 MAb Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Anti-PD-1 MAb Market Facts & Figures
    10.1 Southeast Asia Anti-PD-1 MAb Sales by Company
        10.1.1 Southeast Asia Anti-PD-1 MAb Sales by Company (2016-2021)
        10.1.2 Southeast Asia Anti-PD-1 MAb Revenue by Company (2016-2021)
    10.2 Southeast Asia Anti-PD-1 MAb Sales Breakdown by Type
        10.2.1 Southeast Asia Anti-PD-1 MAb Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Anti-PD-1 MAb Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Anti-PD-1 MAb Sales Breakdown by Application
        10.3.1 Southeast Asia KG Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia KG Sales Breakdown by Application (2022-2027)

11 India Anti-PD-1 MAb Market Facts & Figures
    11.1 India Anti-PD-1 MAb Sales by Company
        11.1.1 India Anti-PD-1 MAb Sales by Company (2016-2021)
        11.1.2 India Anti-PD-1 MAb Revenue by Company (2016-2021)
    11.2 India Anti-PD-1 MAb Sales Breakdown by Type
        11.2.1 India Anti-PD-1 MAb Sales Breakdown by Type (2016-2021)
        11.2.2 India Anti-PD-1 MAb Sales Breakdown by Type (2022-2027)
    11.3 India Anti-PD-1 MAb Sales Breakdown by Application
        11.3.1 India Anti-PD-1 MAb Sales Breakdown by Application (2016-2021)
        11.3.2 India Anti-PD-1 MAb Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Anti-PD-1 MAb Business
    12.1 Bristol Myers Squibb
        12.1.1 Bristol Myers Squibb Corporation Information
        12.1.2 Bristol Myers Squibb Business Overview
        12.1.3 Bristol Myers Squibb Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Bristol Myers Squibb Anti-PD-1 MAb Products Offered
        12.1.5 Bristol Myers Squibb Recent Development
    12.2 Merck
        12.2.1 Merck Corporation Information
        12.2.2 Merck Business Overview
        12.2.3 Merck Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Merck Anti-PD-1 MAb Products Offered
        12.2.5 Merck Recent Development
    12.3 Junshi Pharma
        12.3.1 Junshi Pharma Corporation Information
        12.3.2 Junshi Pharma Business Overview
        12.3.3 Junshi Pharma Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Junshi Pharma Anti-PD-1 MAb Products Offered
        12.3.5 Junshi Pharma Recent Development
    12.4 Innovent Biologics Inc
        12.4.1 Innovent Biologics Inc Corporation Information
        12.4.2 Innovent Biologics Inc Business Overview
        12.4.3 Innovent Biologics Inc Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Innovent Biologics Inc Anti-PD-1 MAb Products Offered
        12.4.5 Innovent Biologics Inc Recent Development
    12.5 Hengrui Medicine
        12.5.1 Hengrui Medicine Corporation Information
        12.5.2 Hengrui Medicine Business Overview
        12.5.3 Hengrui Medicine Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Hengrui Medicine Anti-PD-1 MAb Products Offered
        12.5.5 Hengrui Medicine Recent Development
    12.6 Beijing Beigene
        12.6.1 Beijing Beigene Corporation Information
        12.6.2 Beijing Beigene Business Overview
        12.6.3 Beijing Beigene Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Beijing Beigene Anti-PD-1 MAb Products Offered
        12.6.5 Beijing Beigene Recent Development
    ...

13 Anti-PD-1 MAb Manufacturing Cost Analysis
    13.1 Anti-PD-1 MAb Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Anti-PD-1 MAb
    13.4 Anti-PD-1 MAb Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Anti-PD-1 MAb Distributors List
    14.3 Anti-PD-1 MAb Customers

15 Market Dynamics
    15.1 Anti-PD-1 MAb Market Trends
    15.2 Anti-PD-1 MAb Drivers
    15.3 Anti-PD-1 MAb Market Challenges
    15.4 Anti-PD-1 MAb Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer
List of Tables
    Table 1. Global Anti-PD-1 MAb Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Anti-PD-1 MAb Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Anti-PD-1 MAb Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Anti-PD-1 MAb Sales (KG) by Region (2016-2021)
    Table 5. Global Anti-PD-1 MAb Sales Market Share by Region (2016-2021)
    Table 6. Global Anti-PD-1 MAb Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Anti-PD-1 MAb Revenue Share by Region (2016-2021)
    Table 8. Global Anti-PD-1 MAb Sales (KG) Forecast by Region (2022-2027)
    Table 9. Global Anti-PD-1 MAb Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Anti-PD-1 MAb Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Anti-PD-1 MAb Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Anti-PD-1 MAb Sales (KG) of Key Companies (2016-2021)
    Table 13. Global Anti-PD-1 MAb Sales Share by Company (2016-2021)
    Table 14. Global Anti-PD-1 MAb Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Anti-PD-1 MAb Revenue Share by Company (2016-2021)
    Table 16. Global Anti-PD-1 MAb by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-PD-1 MAb as of 2020)
    Table 17. Global Anti-PD-1 MAb Average Price (USD/KG) of Key Company (2016-2021)
    Table 18. Manufacturers Anti-PD-1 MAb Manufacturing Sites and Area Served
    Table 19. Manufacturers Anti-PD-1 MAb Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Anti-PD-1 MAb Sales (KG) by Type (2016-2021)
    Table 22. Global Anti-PD-1 MAb Sales Share by Type (2016-2021)
    Table 23. Global Anti-PD-1 MAb Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Anti-PD-1 MAb Price (USD/KG) by Type (2016-2021)
    Table 25. Global Anti-PD-1 MAb Sales Share by Type (2022-2027)
    Table 26. Global Anti-PD-1 MAb Revenue (US$ Million) Market Share by Type (2022-2027) 
    Table 27. Global Anti-PD-1 MAb Revenue Share by Type (2022-2027)
    Table 28. Global Anti-PD-1 MAb Price (USD/KG) by Type (2022-2027)
    Table 29. Global Anti-PD-1 MAb Sales (KG) by Application (2016-2021) 
    Table 30. Global Anti-PD-1 MAb Sales Share by Application (2016-2021)
    Table 31. Global Anti-PD-1 MAb Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Anti-PD-1 MAb Price (USD/KG) by Application (2016-2021)
    Table 33. Global Anti-PD-1 MAb Sales (KG) by Application (2022-2027)
    Table 34. Global Anti-PD-1 MAb Sales Share by Application (2022-2027)
    Table 35. Global Anti-PD-1 MAb Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Anti-PD-1 MAb Revenue Share by Application (2022-2027)
    Table 37. Global Anti-PD-1 MAb Price (USD/KG) by Application (2022-2027)
    Table 38. North America Anti-PD-1 MAb Sales (KG) by Company (2016-2021)
    Table 39. North America Anti-PD-1 MAb Sales Market Share by Company (2016-2021)
    Table 40. North America Anti-PD-1 MAb Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Anti-PD-1 MAb Revenue Market Share by Company (2016-2021)
    Table 42. North America Anti-PD-1 MAb Sales by Type (2016-2021) & (KG)
    Table 43. North America Anti-PD-1 MAb Sales Market Share by Type (2016-2021)
    Table 44. North America Anti-PD-1 MAb Sales by Type (2022-2027) & (KG)
    Table 45. North America Anti-PD-1 MAb Sales Market Share by Type (2022-2027)
    Table 46. North America Anti-PD-1 MAb Sales by Application (2016-2021) & (KG)
    Table 47. North America Anti-PD-1 MAb Sales Market Share by Application (2016-2021)
    Table 48. North America Anti-PD-1 MAb Sales by Application (2022-2027) & (KG)
    Table 49. North America Anti-PD-1 MAb Sales Market Share by Application (2022-2027)
    Table 50. Europe Anti-PD-1 MAb Sales (KG) by Company (2016-2021)
    Table 51. Europe Anti-PD-1 MAb Sales Market Share by Company (2016-2021)
    Table 52. Europe Anti-PD-1 MAb Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Anti-PD-1 MAb Revenue Market Share by Company (2016-2021)
    Table 54. Europe Anti-PD-1 MAb Sales by Type (2016-2021) & (KG)
    Table 55. Europe Anti-PD-1 MAb Sales Market Share by Type (2016-2021)
    Table 56. Europe Anti-PD-1 MAb Sales by Type (2022-2027) & (KG)
    Table 57. Europe Anti-PD-1 MAb Sales Market Share by Type (2022-2027)
    Table 58. Europe Anti-PD-1 MAb Sales by Application (2016-2021) & (KG)
    Table 59. Europe Anti-PD-1 MAb Sales Market Share by Application (2016-2021)
    Table 60. Europe Anti-PD-1 MAb Sales by Application (2022-2027) & (KG)
    Table 61. Europe Anti-PD-1 MAb Sales Market Share by Application (2022-2027)
    Table 62. China Anti-PD-1 MAb Sales (KG) by Company (2016-2021)
    Table 63. China Anti-PD-1 MAb Sales Market Share by Company (2016-2021)
    Table 64. China Anti-PD-1 MAb Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Anti-PD-1 MAb Revenue Market Share by Company (2016-2021)
    Table 66. China Anti-PD-1 MAb Sales by Type (2016-2021) & (KG)
    Table 67. China Anti-PD-1 MAb Sales Market Share by Type (2016-2021)
    Table 68. China Anti-PD-1 MAb Sales by Type (2022-2027) & (KG)
    Table 69. China Anti-PD-1 MAb Sales Market Share by Type (2022-2027)
    Table 70. China Anti-PD-1 MAb Sales by Application (2016-2021) & (KG)
    Table 71. China Anti-PD-1 MAb Sales Market Share by Application (2016-2021)
    Table 72. China Anti-PD-1 MAb Sales by Application (2022-2027) & (KG)
    Table 73. China Anti-PD-1 MAb Sales Market Share by Application (2022-2027)
    Table 74. Japan Anti-PD-1 MAb Sales (KG) by Company (2016-2021)
    Table 75. Japan Anti-PD-1 MAb Sales Market Share by Company (2016-2021)
    Table 76. Japan Anti-PD-1 MAb Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Anti-PD-1 MAb Revenue Market Share by Company (2016-2021)
    Table 78. Japan Anti-PD-1 MAb Sales by Type (2016-2021) & (KG)
    Table 79. Japan Anti-PD-1 MAb Sales Market Share by Type (2016-2021)
    Table 80. Japan Anti-PD-1 MAb Sales by Type (2022-2027) & (KG)
    Table 81. Japan Anti-PD-1 MAb Sales Market Share by Type (2022-2027)
    Table 82. Japan Anti-PD-1 MAb Sales by Application (2016-2021) & (KG)
    Table 83. Japan Anti-PD-1 MAb Sales Market Share by Application (2016-2021)
    Table 84. Japan Anti-PD-1 MAb Sales by Application (2022-2027) & (KG)
    Table 85. Japan Anti-PD-1 MAb Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Anti-PD-1 MAb Sales (KG) by Company (2016-2021)
    Table 87. Southeast Asia Anti-PD-1 MAb Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Anti-PD-1 MAb Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Anti-PD-1 MAb Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Anti-PD-1 MAb Sales by Type (2016-2021) & (KG)
    Table 91. Southeast Asia Anti-PD-1 MAb Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Anti-PD-1 MAb Sales by Type (2022-2027) & (KG)
    Table 93. Southeast Asia Anti-PD-1 MAb Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Anti-PD-1 MAb Sales by Application (2016-2021) & (KG)
    Table 95. Southeast Asia Anti-PD-1 MAb Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Anti-PD-1 MAb Sales by Application (2022-2027) & (KG)
    Table 97. Southeast Asia Anti-PD-1 MAb Sales Market Share by Application (2022-2027)
    Table 98. India Anti-PD-1 MAb Sales (KG) by Company (2016-2021)
    Table 99. India Anti-PD-1 MAb Sales Market Share by Company (2016-2021)
    Table 100. India Anti-PD-1 MAb Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Anti-PD-1 MAb Revenue Market Share by Company (2016-2021)
    Table 102. India Anti-PD-1 MAb Sales by Type (2016-2021) & (KG)
    Table 103. India Anti-PD-1 MAb Sales Market Share by Type (2016-2021)
    Table 104. India Anti-PD-1 MAb Sales by Type (2022-2027) & (KG)
    Table 105. India Anti-PD-1 MAb Sales Market Share by Type (2022-2027)
    Table 106. India Anti-PD-1 MAb Sales by Application (2016-2021) & (KG)
    Table 107. India Anti-PD-1 MAb Sales Market Share by Application (2016-2021)
    Table 108. India Anti-PD-1 MAb Sales by Application (2022-2027) & (KG)
    Table 109. India Anti-PD-1 MAb Sales Market Share by Application (2022-2027)
    Table 110. Bristol Myers Squibb Corporation Information
    Table 111. Bristol Myers Squibb Description and Business Overview
    Table 112. Bristol Myers Squibb Anti-PD-1 MAb Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2016-2021)
    Table 113. Bristol Myers Squibb Anti-PD-1 MAb Product
    Table 114. Bristol Myers Squibb Recent Development
    Table 115. Merck Corporation Information
    Table 116. Merck Description and Business Overview
    Table 117. Merck Anti-PD-1 MAb Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2016-2021)
    Table 118. Merck Anti-PD-1 MAb Product
    Table 119. Merck Recent Development
    Table 120. Junshi Pharma Corporation Information
    Table 121. Junshi Pharma Description and Business Overview
    Table 122. Junshi Pharma Anti-PD-1 MAb Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2016-2021)
    Table 123. Junshi Pharma Anti-PD-1 MAb Product
    Table 124. Junshi Pharma Recent Development
    Table 125. Innovent Biologics Inc Corporation Information
    Table 126. Innovent Biologics Inc Description and Business Overview
    Table 127. Innovent Biologics Inc Anti-PD-1 MAb Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2016-2021)
    Table 128. Innovent Biologics Inc Anti-PD-1 MAb Product
    Table 129. Innovent Biologics Inc Recent Development
    Table 130. Hengrui Medicine Corporation Information
    Table 131. Hengrui Medicine Description and Business Overview
    Table 132. Hengrui Medicine Anti-PD-1 MAb Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2016-2021)
    Table 133. Hengrui Medicine Anti-PD-1 MAb Product
    Table 134. Hengrui Medicine Recent Development
    Table 135. Beijing Beigene Corporation Information
    Table 136. Beijing Beigene Description and Business Overview
    Table 137. Beijing Beigene Anti-PD-1 MAb Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2016-2021)
    Table 138. Beijing Beigene Anti-PD-1 MAb Product
    Table 139. Beijing Beigene Recent Development
    Table 140. Production Base and Market Concentration Rate of Raw Material
    Table 141. Key Suppliers of Raw Materials
    Table 142. Anti-PD-1 MAb Distributors List
    Table 143. Anti-PD-1 MAb Customers List
    Table 144. Anti-PD-1 MAb Market Trends
    Table 145. Anti-PD-1 MAb Market Drivers
    Table 146. Anti-PD-1 MAb Market Challenges
    Table 147. Anti-PD-1 MAb Market Restraints
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-PD-1 MAb Product Picture
    Figure 2. Global Anti-PD-1 MAb Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Anti-PD-1 MAb Sales Market Share by Application in 2021 & 2027
    Figure 6. Melanoma Patients Examples
    Figure 7. Lung Cancer Patients Examples
    Figure 8. Lymphoma Patients Examples
    Figure 9. Other Examples
    Figure 10. Global Anti-PD-1 MAb Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Anti-PD-1 MAb Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 12. Global Anti-PD-1 MAb Sales (KG) Growth Rate (2016-2027)
    Figure 13. Global Anti-PD-1 MAb Price Trends Growth Rate (2016-2027) (USD/KG)
    Figure 14. Global Anti-PD-1 MAb Revenue Market Share by Region: 2016 VS 2021
    Figure 15. Global Anti-PD-1 MAb Revenue Market Share by Region: 2021 VS 2027
    Figure 16. North America Anti-PD-1 MAb Revenue (Million USD) Growth Rate (2016-2027)
    Figure 17. North America Anti-PD-1 MAb Sales (KG) Growth Rate (2016-2027)
    Figure 18. Europe Anti-PD-1 MAb Revenue (Million USD) Growth Rate (2016-2027)
    Figure 19. Europe Anti-PD-1 MAb Sales (Million USD) Growth Rate (2016-2027)
    Figure 20. China Anti-PD-1 MAb Revenue (Million USD) Growth Rate (2016-2027)
    Figure 21. China Anti-PD-1 MAb Sales (Million USD) and Growth Rate (2016-2027)
    Figure 22. Japan Anti-PD-1 MAb Revenue (Million USD) Growth Rate (2016-2027)
    Figure 23. Japan Anti-PD-1 MAb Sales (Million USD) Growth Rate (2016-2027)
    Figure 24. Southeast Asia Anti-PD-1 MAb Revenue (Million USD) Growth Rate (2016-2027)
    Figure 25. Southeast Asia Anti-PD-1 MAb Sales (Million USD) Growth Rate (2016-2027)
    Figure 26. India Anti-PD-1 MAb Revenue (Million USD) Growth Rate (2016-2027)
    Figure 27. India Anti-PD-1 MAb Sales (Million USD) Growth Rate (2016-2027)
    Figure 28. Global 5 Largest Anti-PD-1 MAb Players Market Share by Revenue in Anti-PD-1 MAb: 2016 & 2020
    Figure 29. Anti-PD-1 MAb Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 30. Global Anti-PD-1 MAb Revenue Share by Type (2016-2021)
    Figure 31. Global Anti-PD-1 MAb Revenue Growth Rate by Type in 2016 & 2020
    Figure 32. Global Anti-PD-1 MAb Revenue Share by Application (2016-2021)
    Figure 33. Global Anti-PD-1 MAb Revenue Growth Rate by Application in 2016 & 2020
    Figure 34. North America Anti-PD-1 MAb Sales Market Share by Type in 2020
    Figure 35. North America Anti-PD-1 MAb Sales Market Share by Application in 2020
    Figure 36. Europe Anti-PD-1 MAb Sales Market Share by Type in 2020
    Figure 37. Europe Anti-PD-1 MAb Sales Market Share by Application in 2020
    Figure 38. China Anti-PD-1 MAb Sales Market Share by Type in 2020
    Figure 39. China Anti-PD-1 MAb Sales Market Share by Application in 2020
    Figure 40. Japan Anti-PD-1 MAb Sales Market Share by Type in 2020
    Figure 41. Japan Anti-PD-1 MAb Sales Market Share by Application in 2020
    Figure 42. Southeast Asia Anti-PD-1 MAb Sales Market Share by Type in 2020
    Figure 43. Southeast Asia Anti-PD-1 MAb Sales Market Share by Application in 2020
    Figure 44. India Anti-PD-1 MAb Sales Market Share by Type in 2020
    Figure 45. India Anti-PD-1 MAb Sales Market Share by Application in 2020
    Figure 46. Key Raw Materials Price Trend
    Figure 47. Manufacturing Cost Structure of Anti-PD-1 MAb 
    Figure 48. Manufacturing Process Analysis of Anti-PD-1 MAb
    Figure 49. Anti-PD-1 MAb Industrial Chain Analysis
    Figure 50. Channels of Distribution
    Figure 51. Distributors Profiles
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation 
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bristol Myers Squibb
Merck
Junshi Pharma
Innovent Biologics Inc
Hengrui Medicine
Beijing Beigene
Frequently Asked Questions
Anti-PD-1 MAb report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Anti-PD-1 MAb report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Anti-PD-1 MAb report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports